Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 263

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 263
---
 48,982 |
| Write-off of prepayment and other receivables |     |   |        9,782 |     |   |            — |
| Other expenses                                |     |   |       14,802 |     |   |      186,098 |
| Total General and Administrative Fees         |     | $ |      669,486 |     | $ |    1,930,637 |

Legal and professional fees For the years ended December 31, 2024, and 2023, the legal and professional fees were $803,285 and $2,538,161, respectively. The decrease in legal and professional fees was primarily attributed to the lack of non -routineactivities that were present in the same period last year, such as the implementation of reverse stock split, and amendments to the memorandum and articles of association. The absence of such non -routineexercises in the current period has resulted in a decrease in legal and professional fees. Other operating expenses For the years ended December 31, 2024, and 2023, the other operating expenses was $272,609 and $1,067,690, respectively. The decrease in other operating expenses was primarily due to the decrease in impairment loss of long -livedassets since the majority of long -livedassets were impaired in prior year and no such large impairment in current year. Other (expense) income, net For the years ended December 31, 2024, and 2023, the other expense, net, was $217,196 and other income, net, was $6,383,276, respectively. The changes from other income in 2023 to other expense in 2024 was mainly due to there was a one -offunrealized gain from fair value change of the long -terminvestments, amounted to $6.4 million in prior year, which there are no such gain in current year. Net loss attributable to the Company For the years ended December 31, 2024, and 2023, net loss attributable to the Company (excluding net loss attributable to non -controllinginterests) was $4,267,806 and $2,824,647, respectively. Results of Operations for the Years ended December 31, 2023, and 2022 During the second quarter of 2023, the Company made a decision to streamline its operations by terminating clinic services and suspending non -leadR&D projects. This measure is aimed